Veru to present corporate update at the h.c. wainwright bioconnect conference on january 10-13, 2022

Miami, jan. 03, 2022 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, today announced that the company will present at the h.c. wainwright bioconnect conference. the presentation will be available through the conference from january 10-13, 2022, beginning at 7:00 am eastern standard time on january 10th.
VERU Ratings Summary
VERU Quant Ranking